>peptide 1 (29 aa)
PGNARRKRLRVITITNSLITISLIETLNL*
>peptide 2 (159 aa)
MSEEGGKMNREAPAMVAATGEPLPANYYYGTFQGVANYQTPPSQSQPVLGFPQPIPPPGVPVVPPCYYPHGYQTVQGYVVAEGRPIREHRLPCCGMGIGW
FLFIIGFFLGAIPWYIGAFLLLCARLDYREKPGFIACTLAATLALVAVTLGATKVNYSW*
>peptide 3 (31 aa)
MKGKGIFTNMSTVGFHWVCCLESSFITAICI*
>peptide 4 (33 aa)
MHLSSYTCFGCCDSWCNKGKLFLVRDRFMLQML*
>peptide 5 (60 aa)
MLPFNLLQERSKLSISCRLEKVFGILPMRWLCDRFNACILLMFPNSTGISPVNLLLERSIP
>peptide 6 (50 aa)
MYSSKVFVKMANINAVFDLEDCTILFFGFLWKRLTIHLALYRFRLFCFGL*
>CNT0010524
GTCCGGGCAATGCTAGGCGTAAACGTCTCCGAGTGATCACTATAACAAATTCGCTGATCACAATCTCTTTGATCGAAACCCTAAACCTTTGATCGATCGA
ACGGTGAAGAATGAGCGAAGAGGGTGGAAAGATGAACAGAGAAGCTCCGGCAATGGTGGCAGCCACCGGCGAGCCATTGCCGGCTAACTATTACTACGGG
ACATTTCAAGGAGTCGCCAATTATCAAACTCCTCCTTCGCAATCTCAACCGGTCTTGGGTTTCCCTCAACCTATACCTCCTCCAGGTGTCCCCGTTGTTC
CTCCGTGTTACTATCCTCATGGTTATCAGACCGTTCAAGGTTATGTTGTTGCCGAAGGTAGACCCATAAGGGAGCATCGGCTTCCTTGCTGTGGTATGGG
AATTGGCTGGTTCTTGTTCATTATTGGTTTCTTTCTTGGTGCCATTCCCTGGTACATTGGAGCTTTTCTTCTTTTGTGTGCTCGGCTCGATTATAGAGAA
AAACCTGGATTTATTGCATGCACCTTAGCAGCTACACTTGCTTTGGTTGCTGTGACTCTTGGTGCAACAAAGGTAAATTATTCCTGGTGAGAGACCGATT
CATGCTGCAAATGTTGTAAATTCACACACACACACACACACACACACACATATATATATATATATATATAAAGGAAACGAAAGATAAATGAAAGGGAAGG
GAATTTTCACGAATATGTCCACAGTGGGATTTCACTGGGTATGTTGTTTGGAATCGTCGTTTATTACTGCAATTTGTATATAGCAGATACCAACTGAGTG
ATGCCTATATTCTGGTAATGCAATTCTAAGTTAGTCTTGGTTCAATGTATTCTTCTAAAGTATTTGTTAAAATGGCCAATATAAATGCAGTATTTGATTT
GGAGGATTGTACTATATTGTTTTTTGGATTCCTATGGAAGAGGTTGACAATACATTTAGCATTGTATCGTTTTAGGTTATTTTGTTTTGGTCTATGACTG
TCTCCTTAAGGACAGTAAAAGCCCGTTTGGATTGGCTTAAAAAAAGTAGTCAAAAATAAAAAGTCAAACTGAAATGATTTTTAAGTCAAAAAAATAAAAA
GTATGGCTTAAGTCAAAGTGTTTTGCAAAATCGAAGTTAAAAAAAGGCATACATGAGTCTTTTCTTTAACCACAATGACATAGATGAGCCAAACTTTAAA
AAAAGGATATAAATAAGTTTTTTCTGAAAGTTTGATGACATATTTGAACATTTTCACTTGATTTTAACCATCACGTGTTCCTCTGTTCTATTGGTTAACG
ATTCATAATTTGGACTGTTGGATCTCGAGATATAAATTTTTTCGCTAATACTAGGCCAAAGTGTGATCAGAATTCCAAGCATGTACCTAATTTCAGAAAT
TGATTGCGACCCATCGGAGAGGAGTTTTACAGTGAATGAGTCTTCGGATAGAGCACCAGTTTAATTAATCGAGGCCATTTCTTGTTCATCCCCGGCCCCT
ATAGCAGCTTGGAATGACCTTTATGGTGTAAGTTGGAGGGGTAGTCTGCTGCAAGTGTAGCGTTGAGCGAGATGCCATACGATCGAGCATAGGTAGGAAT
TCCTGACAGCAGGAAGAGAGAAAATGGAGTTGGGTGATGAACTAAGGCTTTCTATCTCTCAATCAATTTGGACCAAACAATGTTAGGACTCATCCCACAC
TTGTTGTCTAATGGATAACCGCAAAGAAAAGGATTTCCCTCGTAGCTGCTTTTGTTGAAAGTTCCAAATTGAGCTTTAAAATCAGGCACTGCACCCGATA
AGTTGTTGTATGCAACACTGAATACTGCCAACGAATTTAGCTCAAGTAGACCAACAGGAATGCTCCCATTCAATCTGTTGCAGGAAAGGTCTAAACTCTC
GATTTCCTGTAGATTGGAGAAGGTATTTGGTATTCTTCCGATGAGATGGTTGTGCGATAGATTCAATGCATGTATATTGCTCATGTTCCCTAACTCAACA
GGAATTTCACCAGTTAATCTATTACTTGAGAGATCAATACCCG
Potential function | Interacting transcript | Gene description | Transcript biotype | lncRNA id | Alignment score (LAST) | Alignment length | Transcript region involved in interaction | Genomic orientation of interacting RNAs |
---|---|---|---|---|---|---|---|---|
PGSC0003DMT400093474 | AtRLP45 (Receptor 45); protein binding | protein coding | CNT0010524 | 1018 | 362 | CDS | Cis |